Company Overview
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, medication adherence packaging, contracted pharmacy services, health practice risk management, disease testing, contracted pharmacy, and vaccinations services, as well as supplies prescription medications. It also operates e-commerce websites, as well as third-party e-commerce storefronts that provide mobile satellite services solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and internet of things connectivity services; voice, data communications, internet of things (IoT), and machine-to-machine services; tracking and monitoring services; satellite communications products; GPS enabled emergency locator distress beacons; satellite tracking devices used to monitor the location, movements, and history of anything that moves; and GTCTrack, a subscription-based mapping and tracking portal that provides a universal and hardware-agnostic, cloud-based data visualization and management platform. In addition, the company provides value-added services, such as prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions. Further, it offers satellite phones, tracking devices, broadband terminals, messaging plans, and connectivity services. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp was founded in 2008 and is headquartered in Hallandale Beach, Florida.
Why Investors Should Care
Revenue has grown at a 33.8% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.10.
Recent Developments
- Dec 2025 Revenue of $54.32M (-17.8% YoY); net profit $-10.46M.
- Trailing 12 Months Year-on-year growth — revenue -10.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 33.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 33.81% |
| 1 Year: | -10.30% |
Stock Price Performance
| 1 Year: | +14.74% |
| 6 Months: | +108.14% |
| 3 Months: | +48.67% |
| 1 Month: | +39.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)60.39 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 33.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NXPL NextPlat Corp TECH | 8.95 | -2.61 | $24.28M | 0.00% | -47.71% | -39.95% | 33.81% | - |
| 2 | NVDA NVIDIA Corporation NDXSPXR3KAITECH | 225.73 | 28.50 | $5.45T | 0.46% | 74.66% | 117.21% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPXR3KTECH | 316.22 | 36.22 | $4.61T | 0.34% | 68.72% | 148.75% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXR3KAITECH | 493.95 | 27.49 | $3.67T | 0.79% | 26.33% | 34.04% | 9.93% | 11.90% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AITECH | 439.00 | 32.71 | $2.28T | 0.95% | 30.20% | 39.97% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXR3KAITECH | 368.56 | 46.95 | $1.75T | 0.71% | 16.70% | 44.25% | 17.04% | 54.08% |
| 7 | MU Micron Technology, Inc. NDXSPXR3KAITECH | 1,000.26 | 22.59 | $1.13T | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH | 505.74 | 128.36 | $825.61B | 0.00% | 5.47% | 10.20% | 11.81% | 66.28% |
| 9 | ASML ASML Holding N.V. NDXAITECH | 1,764.85 | 59.89 | $677.88B | 0.51% | 42.97% | 53.94% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30M | 1.41M | 1.75M | 1.47M | 1.22M | 1.48M | 1.46M | 1.96M | 2.25M | 3.58M | 2.87M | 2.63M | 2.88M | - | - | - | - | - | - | 13.93M | 13.24M | 13.75M | 12.80M | 9.86M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.06M | 10.36M | 11.02M | 10.97M | 6.44M |
| Gross Profit | - | 204.60K | 137.82K | 201.57K | 226.39K | 324.08K | 284.91K | 438.34K | 183.70K | 264.10K | 314.58K | 296.64K | 347.81K | 379.10K | 356.07K | 246.21K | 245.93K | 274.11K | 380.52K | 348.00K | 257.69K | 398.46K | 437.52K | 541.49K | 493.14K | 801.09K | 567.39K | 678.75K | 621.00K | 844.00K | 4.58M | 4.86M | 5.86M | 3.56M | - | 2.86M | 2.88M | 2.73M | 1.83M | 3.41M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.95M | 4.71M | 4.72M | 5.28M | 4.51M |
| Operating Income | -163.41K | 64.82K | -40.30K | 14.26K | -412.98K | -212.40K | -296.51K | -303.68K | -599.15K | -307.70K | -218.46K | -825.29K | -206.69K | -141.08K | -113.04K | -283.18K | -236.80K | -370.12K | -202.52K | -191.24K | -189.24K | -474.37K | -298.93K | -549.34K | -2.24M | -834.62K | -1.53M | -2.16M | -1.24M | -3.35M | -3.48M | -1.84M | -10.90M | -8.00M | - | -2.08M | -1.83M | -1.99M | -3.45M | -1.10M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.79M | -1.48M | -1.95M | -4.91M | -954.00K |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.00K | 18.00K | 15.00K | 14.00K | 17.00K | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.93M | -1.76M | -2.21M | -5.16M | -1.13M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.00K | 31.00K | -26.00K | -14.00K | 0 |
| Net Income | -144.20K | 71.43K | -38.41K | 7.22K | -422.47K | -208.81K | -298.05K | 59.95K | -1.17M | -338.67K | -219.26K | -3.13M | -265.70K | -145.46K | -123.62K | -324.39K | -307.62K | -387.62K | -300.95K | -284.86K | 26.57K | -1.10M | -803.14K | -1.46M | -2.31M | -850.08K | -1.66M | -5.71M | -1.19M | -4.34M | 3.45M | -1.48M | -5.31M | -4.22M | - | -1.94M | -1.79M | -2.19M | -5.15M | -1.12M |
| Diluted EPS | - | 0.00 | -0.02 | 0.00 | -0.07 | -0.02 | -0.03 | 0.00 | -0.04 | -0.01 | -0.51 | -6.98 | -0.51 | -0.15 | -0.14 | -0.36 | - | - | - | - | - | - | - | - | - | -0.09 | -0.18 | -0.60 | -0.08 | -0.24 | 0.17 | -0.08 | - | -0.22 | - | -0.75 | -0.70 | -0.80 | - | -0.42 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 3.95M | 4.70M | 6.00M | 5.73M | 5.87M | 5.69M | - | 11.71M | 37.76M | 66.08M | 54.32M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 9.22M | 26.45M | 49.07M | 43.42M |
| Gross Profit | - | - | - | - | 681.26K | 984.48K | 1.08M | 1.15M | 1.03M | 1.22M | 1.23M | - | 2.49M | 11.31M | 17.01M | 10.91M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 9.69M | 20.64M | 26.38M | 19.66M |
| Operating Income | -4.29M | -1.94M | -4.67M | -573.79K | 13.82K | -1.99M | -1.63M | -1.58M | -1.13M | -1.11M | -2.03M | - | -7.20M | -9.33M | -9.37M | -8.75M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -6.71M | -19.68M | -19.55M | -9.36M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 24.00K | 79.00K | 81.00K | 64.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -7.33M | -22.29M | -22.45M | -10.46M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 87.00K | 28.00K | 71.00K | 0 |
| Net Income | -11.58M | -8.72M | -4.81M | 624.12K | 6.49K | -2.06M | -2.59M | -3.94M | -1.19M | -1.38M | -2.76M | - | -9.16M | -3.78M | -13.43M | -10.46M |
| Diluted EPS | - | - | - | 0.36 | 0.00 | -0.26 | -11.42 | -8.10 | - | - | - | - | -9.60 | -2.20 | -6.50 | -4.40 |
| R&D Expense | - | - | - | - | 0 | 50.00K | 0 | 0 | 0 | - | 0 | 0 | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Apr 2011 | Dec 2011 | Feb 2012 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 186.36K | - | 55.51K | - | 7.52K | - | 442.45K | 4.32M | 3.03M | 3.60M | 2.44M | 2.43M | 2.63M | - | 28.64M | 64.47M | 37.08M | 27.46M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.18M | 43.64M | 32.08M | 24.16M |
| Cash & Equivalents | - | 94.05K | 56.33K | 15.05K | - | 20 | 78.41K | 65.89K | 963.33K | 114.73K | 233.33K | 142.89K | 75.36K | 728.76K | - | 18.89M | 26.31M | 19.96M | 13.71M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.29M | 5.13M | 4.88M | 3.40M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 384.00K | 8.92M | 5.01M | 4.49M |
| Total Liabilities | - | 7.40M | - | 688.76K | - | - | - | 388.08K | 1.43M | 720.62K | 1.20M | 1.06M | 1.79M | 2.07M | - | 2.87M | 16.38M | 9.68M | 10.04M |
| Current Liabilities | - | 7.08M | - | 688.76K | - | 1.72M | 765.83K | 388.08K | 1.13M | 720.62K | 1.20M | 1.06M | 1.44M | 1.52M | - | 2.06M | 14.24M | 8.21M | 9.13M |
| Long Term Debt | - | - | - | - | 105.88K | - | - | - | - | - | - | - | - | - | - | 156.00K | 1.21M | 1.03M | 876.00K |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07M | 3.01M | 2.26M | 1.49M |
| Total Equity | -242.45K | -7.21M | -12.71M | -633.25K | - | -1.71M | 50.60K | 54.37K | 2.88M | 2.31M | 1.86M | 1.38M | 639.71K | 565.19K | - | 25.78M | 32.18M | 27.28M | 17.31M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.44M | 1.87M | 2.60M | 2.68M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -806.06K | -754.01K | -192.53K | -20 | 21.86K | -620.94K | -1.04M | -315.25K | -590.18K | -659.20K | -836.98K | - | -3.60M | -3.60M | -5.46M | -6.13M |
| Investing Cash Flow | -312.82K | - | - | - | -31.64K | -559.91K | -26.45K | -33.19K | -30.33K | -70.19K | -34.90K | - | -7.72M | 5.20M | -953.00K | 163.00K |
| Financing Cash Flow | 1.21M | 675.00K | 177.50K | - | -31 | 2.09M | 242.57K | 439.55K | 532.03K | 659.33K | 1.57M | - | 13.01M | 5.86M | 72.00K | -225.00K |
| Capital Expenditure | -23.45K | - | - | - | -31.64K | -90.85K | -26.45K | -33.19K | -30.33K | -70.19K | -34.90K | - | -716.00K | -647.00K | -189.00K | -71.00K |
| Free Cash Flow | -829.51K | - | - | - | -9.77K | -711.79K | -1.07M | -348.44K | -620.52K | -729.40K | -871.88K | - | -4.32M | -4.24M | -5.65M | -6.20M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | 1.69M | 7.46M | -6.34M | -6.19M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 100.00K |
| Dividends Paid | - | - | - | - | 133.27K | - | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | 24.9% | 22.9% | 19.2% | 18.1% | 20.8% | 21.5% | - | 21.3% | 30.0% | 25.7% | 20.1% |
| Operating Margin % | - | - | - | - | - | -50.4% | -34.7% | -26.3% | -19.7% | -18.9% | -35.7% | - | -61.5% | -24.7% | -14.2% | -16.1% |
| Net Margin % | - | - | - | - | - | -52.3% | -55.1% | -65.6% | -20.9% | -23.5% | -48.6% | - | -78.2% | -10.0% | -20.3% | -19.3% |
| ROE % | 160.6% | 1,377.4% | 281.7% | 1,233.5% | 11.9% | -71.6% | -112.1% | -211.8% | -86.7% | -215.7% | -488.9% | - | -35.5% | -11.7% | -49.2% | -60.5% |
| ROCE % | 62.2% | 306.9% | 273.5% | - | 25.4% | -62.4% | -70.6% | -65.7% | -81.9% | -113.1% | -182.0% | - | -27.1% | -18.6% | -32.5% | -47.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Eversource Wealth Advisors, Llc | 2.14% | 58.07K | $549.31K |
| 2 | Geode Capital Management, LLC | 0.81% | 21.99K | $208.04K |
| 3 | Vanguard Capital Management LLC | 0.79% | 21.42K | $202.65K |
| 4 | Citadel Advisors Llc | 0.68% | 18.58K | $175.78K |
| 5 | Vanguard Fiduciary Trust Co | 0.33% | 9.06K | $85.67K |
| 6 | Tower Research Capital LLC (TRC) | 0.02% | 642 | $6.07K |
| 7 | Vanguard Global Advisers, LLC | 0.01% | 264 | $2.50K |
| 8 | SBI Securities Co., Ltd. | - | 5 | $47 |
| 9 | UBS Group AG | - | 1 | $9 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NXPL
NextPlat Corp (NXPL) (Q2 2026) Earnings Call Highlights: Record Margins and Strategic Shift ...
NextPlat Corp (NXPL) reports record 40% gross margin and expects bottom-line profitability starting in Q3 2026, fueled by a 136% surge in contracted pharmacy revenue.
NextPlat's PharmcoRx Earns NABP Specialty Pharmacy Accreditation Strengthening its Credentials for New Opportunities with Healthcare Institutions and Providers
NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide,today announced that its PharmcoRx su…
NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue
NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide,today announced the strategic acquisi…
NextPlat (NXPL) Q1 2026 Earnings Transcript
Certain statements made during this conference call constitute forward-looking statements. The words believe, forecast, project, intend, expect, plan, should, would, and similar expressions in all statements which are not historical facts …
NextPlat Corp (NXPL) Q1 2026 Earnings Call Highlights: Margin Expansion and Strategic Growth ...
NextPlat Corp (NXPL) reports improved operating results and strategic advancements despite a dip in total net revenues.
NextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%
NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced improved oper…
NXPL — Frequently Asked Questions
What is the current share price of NextPlat Corp (NXPL)?
As of 2026-09-19 21:16 PDT, NextPlat Corp (NXPL) trades at $8.95 on NasdaqCM. Its 52-week range is $3.70 to $9.80.
What is the market capitalisation of NXPL?
NextPlat Corp (NXPL) has a market capitalisation of $24.28M on NasdaqCM.
What is the P/E ratio of NXPL?
NXPL trades at a trailing price-to-earnings (P/E) ratio of -2.61. The industry average P/E is 29.22. Its price-to-book (P/B) ratio is 1.57.
What is the return on equity (ROE) of NXPL?
NXPL has a return on equity (ROE) of -39.95%. Its return on capital employed (ROCE) is -47.71%.
Is NXPL a good stock to buy?
This page provides a data-driven analysis of NextPlat Corp (NXPL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.